drugset / Trial / NCT00525616
Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The aim of the study is to assess that it will be possible to control with a single cycle of rituximab patient with bullous pemphigoid.
Timeline
- Start
- 2008-12
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rituximab | Monoclonal antibody | 1000 mg | Intravenous |